Immunome (IMNM) Long-Term Deferred Tax (2021 - 2023)

Immunome's (IMNM) quarterly Long-Term Deferred Tax came in at $130000.0 in Q3 2023, down 60.84% YoY from $332000.0 in Q3 2022, and down 69.91% on a QoQ basis from $432000.0 in Q2 2023.

Immunome (IMNM) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends

Immunome (IMNM) has 3 years of Long-Term Deferred Tax data on file, last reported at $130000.0 in Q3 2023.

  • Quarterly Long-Term Deferred Tax fell 60.84% year-over-year to $130000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $130000.0 (down 60.84% YoY) and the FY2022 annual result came in at $332000.0, changed 0.0% from the prior year.
  • Long-Term Deferred Tax eased to $130000.0 in Q3 2023, from $432000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $432000.0 in Q2 2023 to a low of $130000.0 in Q3 2023.
  • A 3-year average of $323444.4 and a median of $332000.0 in 2021 frame the typical range for Long-Term Deferred Tax.
  • The widest YoY moves for Long-Term Deferred Tax: up 30.12% in 2023, down 60.84% in 2023.
  • Tracing IMNM's Long-Term Deferred Tax over 3 years: stood at $332000.0 in 2021, then changed by 0.0% to $332000.0 in 2022, then sank by 60.84% to $130000.0 in 2023.
  • The last three Long-Term Deferred Tax figures came in at $130000.0 (Q3 2023), $432000.0 (Q2 2023), and $332000.0 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immunome 3.09 Bn 2.57 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 130,000.00
Jun 30, 2023 432,000.00
Mar 31, 2023 332,000.00
Dec 31, 2022 332,000.00
Sep 30, 2022 332,000.00
Jun 30, 2022 332,000.00
Mar 31, 2022 382,000.00
Dec 31, 2021 332,000.00
Sep 30, 2021 307,000.00